658 related articles for article (PubMed ID: 18485401)
1. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
[TBL] [Abstract][Full Text] [Related]
2. Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation.
Goel RK; Kaouk JH
Curr Opin Urol; 2008 Sep; 18(5):467-73. PubMed ID: 18670269
[TBL] [Abstract][Full Text] [Related]
3. Surgical Salvage of Thermal Ablation Failures for Renal Cell Carcinoma.
Jiménez JA; Zhang Z; Zhao J; Abouassaly R; Fergany A; Gong M; Kaouk J; Krishnamurthi V; Stein R; Stephenson A; Campbell SC
J Urol; 2016 Mar; 195(3):594-600. PubMed ID: 26417642
[TBL] [Abstract][Full Text] [Related]
4. Thermal ablation of small renal masses: intermediate outcomes from a Canadian center.
Erdeljan P; Dhar M; Wignall G; Kozak R; Pautler SE
Can J Urol; 2011 Oct; 18(5):5903-7. PubMed ID: 22018153
[TBL] [Abstract][Full Text] [Related]
5. Salvage of local recurrence after primary thermal ablation for small renal masses.
Nguyen CT; Campbell SC
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1899-905. PubMed ID: 19046110
[TBL] [Abstract][Full Text] [Related]
6. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.
Johnson DB; Solomon SB; Su LM; Matsumoto ED; Kavoussi LR; Nakada SY; Moon TD; Shingleton WB; Cadeddu JA
J Urol; 2004 Sep; 172(3):874-7. PubMed ID: 15310987
[TBL] [Abstract][Full Text] [Related]
7. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
Kunkle DA; Egleston BL; Uzzo RG
J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
[TBL] [Abstract][Full Text] [Related]
8. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study.
Matin SF; Ahrar K; Cadeddu JA; Gervais DA; McGovern FJ; Zagoria RJ; Uzzo RG; Haaga J; Resnick MI; Kaouk J; Gill IS
J Urol; 2006 Nov; 176(5):1973-7. PubMed ID: 17070224
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive nephron sparing management for renal tumors in solitary kidneys.
Turna B; Kaouk JH; Frota R; Stein RJ; Kamoi K; Gill IS; Novick AC
J Urol; 2009 Nov; 182(5):2150-7. PubMed ID: 19758655
[TBL] [Abstract][Full Text] [Related]
10. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
[TBL] [Abstract][Full Text] [Related]
11. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
12. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors.
Weight CJ; Kaouk JH; Hegarty NJ; Remer EM; O'Malley CM; Lane BR; Gill IS; Novick AC
J Urol; 2008 Apr; 179(4):1277-81; discussion 1281-3. PubMed ID: 18280507
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
14. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
[TBL] [Abstract][Full Text] [Related]
16. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma.
Nosnik IP; Mouraviev V; Nelson R; Polascik TJ
Urology; 2006 Dec; 68(6):1343.e1-3. PubMed ID: 17141824
[TBL] [Abstract][Full Text] [Related]
17. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure?
Stern JM; Anderson JK; Lotan Y; Park S; Cadeddu JA
J Urol; 2006 Nov; 176(5):1969-72; discussion 1972. PubMed ID: 17070222
[TBL] [Abstract][Full Text] [Related]
20. Nephron-sparing probe ablative therapy: long-term outcomes.
Matin SF; Ahrar K
Curr Opin Urol; 2008 Mar; 18(2):150-6. PubMed ID: 18303535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
